These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4612607)

  • 21. Clinical aspects of cancer immunity.
    Moore GE
    Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development in the immunotherapy of malignant melanoma].
    Tritsch H
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM; Cerni C; Micksche M
    Oncology; 1977; 34(5):229-33. PubMed ID: 917456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer and specific active immunization of patients with malignant melanoma.
    Seigler H; Buckley CE; Sheppard LB; Horne BJ; Shingleton WW
    Ann N Y Acad Sci; 1976; 277(00):522-32. PubMed ID: 1069561
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy of human cancer.
    Baker MA; Taub RN
    Prog Allergy; 1973; 17():227-99. PubMed ID: 4591687
    [No Abstract]   [Full Text] [Related]  

  • 26. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour immunology.
    Symes MO
    Br J Surg; 1974 Dec; 61(12):929-38. PubMed ID: 4441810
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunology and cutaneous malignant melanoma.
    Sober AJ
    Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238
    [No Abstract]   [Full Text] [Related]  

  • 29. The therapy of malignant melanoma with transfer factor. A preliminary report.
    Price FB; Hewlett JS; Deodhar SD; Barna B
    Cleve Clin Q; 1974; 41(1):1-4. PubMed ID: 4545020
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
    Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunology of cancer: avenues to immunotherapy.
    Woods AH
    Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular and humoral immunity against human malignant melanoma.
    Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
    Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ; Pierce GE
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract]   [Full Text] [Related]  

  • 34. [Problems of the immunotherapy of malignant neoplasma].
    Trapeznikov NN; Iavorskiĭ VV
    Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated immunity to tumor cells.
    Herberman RB
    Adv Cancer Res; 1974; 19(0):207-63. PubMed ID: 4604193
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro testing in tumor immunotherapy.
    Berkelhammer J
    Semin Oncol; 1974 Dec; 1(4):397-408. PubMed ID: 4143489
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity.
    Lieberman R; Epstein W; Fudenberg HH
    Int J Cancer; 1974 Sep; 14(3):401-16. PubMed ID: 4617711
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological monitoring in a controlled trial of immunotherapy in stage IIB malignant melanoma.
    Embleton MJ; Ransom JH; McIllmurray MB; Reeves WG
    Br J Cancer; 1978 Apr; 37(4):497-504. PubMed ID: 565645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunotherapy of malignant melanomas].
    Macher E
    Haematol Blood Transfus; 1978; 21():285-91. PubMed ID: 738638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.